Tildrakizumab efficacy for psoriatic arthritis: 24-week analysis of swollen and tender joint counts and pain.

Authors

Luis R. Espinoza, LSU Health Sciences Center - New Orleans
Rocco Ballerini, Sun Pharma Advanced Research Company
Richard Chou, State University of New York, Buffalo
Stephen J. Rozzo, Sun Pharma Advanced Research Company
Alan M. Mendelsohn, Sun Pharma Advanced Research Company

Document Type

Conference Proceeding

Publication Date

11-28-2020

Publication Title

Journal of the American Academy of Dermatology

Abstract

American Academy of Dermatology 2020 Annual Meeting, Denver, CO

First Page

AB166

Volume

83

Issue

6, Supplement

Comments

Abstract No: 15994

Recommended Citation

Espinoza, Luis R.; Ballerini, Rocco; Chou, Richard; Rozzo, Stephen J.; and Mendelsohn, Alan M., "Tildrakizumab efficacy for psoriatic arthritis: 24-week analysis of swollen and tender joint counts and pain." (2020). School of Medicine Faculty Publications. 1338.
https://digitalscholar.lsuhsc.edu/som_facpubs/1338
10.1016/j.jaad.2020.06.753